Skip to main content
Diasorin logo

Diasorin — Investor Relations & Filings

Ticker · DIA ISIN · IT0003492391 LEI · 8156002878BDF0EE4348 XMIL Manufacturing
Open in API
Filings indexed 809 across all filing types
Latest filing 2026-03-25 Proxy Solicitation & In…
Country IT Italy
Listing XMIL DIA

About Diasorin

https://diasoringroup.com/en

Diasorin is a global leader in the In Vitro Diagnostic (IVD) field, developing, producing, and marketing reagent kits for laboratory diagnostics. The company specializes in immunodiagnostics and molecular diagnostics. Its immunodiagnostics technology is based on detecting antibodies and antigens in fluid samples to identify diseases or measure physiological markers. The molecular diagnostics division provides flexible tools using targeted and multiplex technologies to detect pathogens in biological specimens. Since 2021, Diasorin has also been active in the Life Science business, offering platforms for biomedical research, clinical diagnostics, and drug discovery. Through its product lines, such as the LIAISON® family of analyzers and assays, the company aims to empower healthcare providers with actionable information to improve patient care, enable faster triage, and reduce unnecessary antibiotic use.

Recent filings

Filing Released Lang Actions
Shareholders' Meeting April 29, 2026 - SPAFID proxy form (art. 135-novies TUF)
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a detailed proxy form and voting instruction package for the Diasorin S.p.A. shareholders’ meeting, including proxy appointment, voting sections for each agenda item, and submission instructions. This constitutes materials sent to shareholders to solicit their proxy and inform them about voting procedures. This aligns exactly with the “Proxy Solicitation & Information Statement” category (Code: PSI).
2026-03-25 English
Assemblea Ordinaria degli Azionisti del 29 aprile 2026 – Modulo delega SPAFID (art. 135-novies TUF)
Proxy Solicitation & Information Statement Classification · 93% confidence The document is a detailed proxy (“modulo di conferimento della delega”) and voting instruction form for Diasorin S.p.A.’s Annual General Meeting, including shareholder voting instructions, delegation mechanics under Italian TUF articles, and privacy/legal notices. This is not an announcement of results or a financial report, but materials sent to shareholders to solicit votes and provide information about the meeting resolutions. This aligns with the definition of a Proxy Solicitation & Information Statement (PSI).
2026-03-25 Italian
Report on the remuneration policy for the year 2026 and remuneration paid in the year 2025
Remuneration Information Classification · 90% confidence The document is titled “Report on the Remuneration Policy for the financial year 2026 and on the compensation paid in the financial year 2025” and explicitly references Article 123-ter of the TUF and Article 84-quarter of the Issuers’ Regulation. It is a statutory Remuneration Report detailing the policy, procedures, and actual compensation paid to directors and executives. This matches the definition for Remuneration Information (Code: DEF 14A).
2026-03-25 English
Relazione sulla politica in materia di remunerazione per l'esercizio 2026 e sui compensi corrisposti nell'esercizio 2025
Remuneration Information Classification · 90% confidence The document is titled “Relazione sulla Politica in materia di Remunerazione e sui compensi corrisposti” prepared pursuant to art. 123-ter TUF and art. 84-quater of the Regolamento Emittenti. It is a comprehensive statutory Remuneration Policy and Compensation Report for 2026/2025, detailing executive and director pay, incentive plans, governance, and vote outcomes. This matches our Remuneration Information category (Code DEF 14A: report detailing compensation for top executives and directors).
2026-03-25 Italian
Shareholders' Meeting April 29, 2026 - Reports and motions for resolutions
Proxy Solicitation & Information Statement Classification · 92% confidence The document is titled “Explanatory Reports and Proposals for Resolutions on the Items on the Agenda” for the Shareholders’ Meeting of Diasorin S.p.A. It contains detailed item-by-item explanatory reports (e.g., approval of financial statements and dividend proposals, remuneration policy, stock option plan) prepared in compliance with Italian TUF Articles 84-ter and 125-ter and Consob regulations. Its purpose is to inform shareholders and solicit votes ahead of the AGM – fitting the definition of a Proxy Solicitation & Information Statement. It is not the full annual report, nor merely an announcement of publication, nor a voting result, but rather the proxy materials for the meeting.
2026-03-25 English
Assemblea Ordinaria degli Azionisti 29 aprile 2026 – Relazioni Illustrative e proposte di delibera
Proxy Solicitation & Information Statement Classification · 95% confidence The document is the explanatory reports (“Relazioni Illustrative”) and proposals for the Annual Shareholders’ Meeting (Assemblea degli Azionisti), including agenda items on the annual financial statements, dividend distribution, remuneration policy, and stock option plan. It is not the annual report itself but the materials sent to shareholders to inform and solicit their votes. This matches the definition of a Proxy Solicitation & Information Statement.
2026-03-25 Italian

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.